112 related articles for article (PubMed ID: 1402016)
1. Frequencies of lipopolysaccharide core types among clinical isolates of Escherichia coli defined with monoclonal antibodies.
Gibb AP; Barclay GR; Poxton IR; di Padova F
J Infect Dis; 1992 Nov; 166(5):1051-7. PubMed ID: 1402016
[TBL] [Abstract][Full Text] [Related]
2. Frequencies of lipopolysaccharide core types in Escherichia coli strains from bacteraemic patients.
Appelmelk BJ; An YQ; Hekker TA; Thijs LG; MacLaren DM; de Graaf J
Microbiology (Reading); 1994 May; 140 ( Pt 5)():1119-24. PubMed ID: 7517766
[TBL] [Abstract][Full Text] [Related]
3. The distribution of, and antibody response to, the core lipopolysaccharide region of Escherichia coli isolated from the faeces of healthy humans and cattle.
Gibbs RJ; Stewart J; Poxton IR
J Med Microbiol; 2004 Oct; 53(Pt 10):959-964. PubMed ID: 15358817
[TBL] [Abstract][Full Text] [Related]
4. Distribution of lipopolysaccharide core types among avian pathogenic Escherichia coli in relation to the major phylogenetic groups.
Dissanayake DR; Wijewardana TG; Gunawardena GA; Poxton IR
Vet Microbiol; 2008 Dec; 132(3-4):355-63. PubMed ID: 18597955
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies to enterobacterial common antigen and to Escherichia coli lipopolysaccharide outer core: demonstration of an antigenic determinant shared by enterobacterial common antigen and E. coli K5 capsular polysaccharide.
Peters H; Jürs M; Jann B; Jann K; Timmis KN; Bitter-Suermann D
Infect Immun; 1985 Nov; 50(2):459-66. PubMed ID: 2414223
[TBL] [Abstract][Full Text] [Related]
6. The disaccharide L-alpha-D-heptose1-->7-L-alpha-D-heptose1-->of the inner core domain of Salmonella lipopolysaccharide is accessible to antibody and is the epitope of a broadly reactive monoclonal antibody.
Nnalue NA; Lind SM; Lindberg AA
J Immunol; 1992 Oct; 149(8):2722-8. PubMed ID: 1383323
[TBL] [Abstract][Full Text] [Related]
7. The lipopolysaccharide core type of Escherichia coli O157:H7 and other non-O157 verotoxin-producing E. coli.
Currie CG; Poxton IR
FEMS Immunol Med Microbiol; 1999 May; 24(1):57-62. PubMed ID: 10340713
[TBL] [Abstract][Full Text] [Related]
8. Antigenic and immunogenic differences in lipopolysaccharides of Escherichia coli J5 vaccine strains of different origins.
Appelmelk BJ; Maaskant JJ; Verweij-van Vught AM; van der Meer NM; Thijs BG; MacLaren DM
J Gen Microbiol; 1993 Nov; 139(11):2641-7. PubMed ID: 7506295
[TBL] [Abstract][Full Text] [Related]
9. Immunoprotective murine monoclonal antibodies specific for the outer-core polysaccharide and for the O-antigen of Escherichia coli 0111:B4 lipopolysaccharide (LPS).
Coughlin RT; Bogard WC
J Immunol; 1987 Jul; 139(2):557-61. PubMed ID: 3298431
[TBL] [Abstract][Full Text] [Related]
10. Escherichia coli and appendicitis: phenotypic characteristics of E. coli isolates from inflamed and noninflamed appendices.
Saxén H; Tarkka E; Hannikainen P; Nikku R; Rautio M; Siitonen A
Clin Infect Dis; 1996 Nov; 23(5):1038-42. PubMed ID: 8922799
[TBL] [Abstract][Full Text] [Related]
11. Production of serum antibodies that recognise epitopes located on the R3 region of Escherichia coli core lipopolysaccharides by patients infected with strains of enterohaemorrhagic E. coli.
Chart H; Cheasty T; Willshaw GA
J Med Microbiol; 2002 Dec; 51(12):1050-1054. PubMed ID: 12466402
[TBL] [Abstract][Full Text] [Related]
12. Identification of a cross-reactive epitope widely present in lipopolysaccharide from enterobacteria and recognized by the cross-protective monoclonal antibody WN1 222-5.
Muller-Loennies S; Brade L; MacKenzie CR; Di Padova FE; Brade H
J Biol Chem; 2003 Jul; 278(28):25618-27. PubMed ID: 12716894
[TBL] [Abstract][Full Text] [Related]
13. The importance of the K1 capsule in invasive infections caused by Escherichia coli.
Cross AS; Gemski P; Sadoff JC; Orskov F; Orskov I
J Infect Dis; 1984 Feb; 149(2):184-93. PubMed ID: 6199436
[TBL] [Abstract][Full Text] [Related]
14. A comparison of immunoblotting, flow cytometry and ELISA to monitor the binding of anti-lipopolysaccharide monoclonal antibodies.
Nelson D; Neill W; Poxton IR
J Immunol Methods; 1990 Oct; 133(2):227-33. PubMed ID: 2230140
[TBL] [Abstract][Full Text] [Related]
15. Computerized complex typing of Escherichia coli strains from different clinical materials.
Czirók E; Herpay M; Milch H
Acta Microbiol Hung; 1993; 40(3):217-37. PubMed ID: 8191867
[TBL] [Abstract][Full Text] [Related]
16. Occurrence of K1, K5 and O antigens in Escherichia coli isolates from patients with urinary tract infections or bacteraemia.
Devine DA; Robinson L; Roberts AP
J Med Microbiol; 1989 Dec; 30(4):295-9. PubMed ID: 2481040
[TBL] [Abstract][Full Text] [Related]
17. Neutralizing and cross-reactive antibodies against enterobacterial lipopolysaccharide.
Müller-Loennies S; Brade L; Brade H
Int J Med Microbiol; 2007 Sep; 297(5):321-40. PubMed ID: 17544324
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the Shigella serotype D (S. sonnei) O polysaccharide and the enterobacterial R1 lipopolysaccharide core by use of mouse monoclonal antibodies.
Viret JF; Bruderer U; Lang AB
Infect Immun; 1992 Jul; 60(7):2741-7. PubMed ID: 1612742
[TBL] [Abstract][Full Text] [Related]
19. Cross-reactivity between six Enterobacteriaceae complete lipopolysaccharide core chemotypes.
Nnalue NA; Khan GN; Mustafa N
J Med Microbiol; 1999 May; 48(5):433-441. PubMed ID: 10229540
[TBL] [Abstract][Full Text] [Related]
20. Antigenic epitope in Pseudomonas aeruginosa lipopolysaccharide immunologically cross-reactive with Escherichia coli O26 lipopolysaccharide.
Yokota S; Kaya S; Noguchi H
FEMS Microbiol Lett; 1990 Mar; 56(3):245-8. PubMed ID: 1692796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
